CHU Grenoble-Alpes — Grenoble

Public research footprint of CHU Grenoble-Alpes, compiled from the ClinicalTrials.gov public registry.

275

Registered studies

111

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Pancreatic Cancer · Epithelial Ovarian Cancer · Respiratory Distress Syndrome in Premature Infant · Diffuse Large B-cell Lymphoma

Recently updated registry entries

NCT04526665 — Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (Active Not Recruiting)
NCT06571149 — Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and… (Recruiting)
NCT07742436 — Urinary and Sexual Symptoms in Patients With Hirschsprung Disease (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Grenoble-Alpes?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.